BIOLASE, Inc. (BIOL)
USD 0.02
(27.39%)
USD 0.02
(27.39%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 16.72 Million USD | 5.11% |
| 2022 | 15.91 Million USD | -3.74% |
| 2021 | 16.52 Million USD | 167.76% |
| 2020 | 6.17 Million USD | -56.8% |
| 2019 | 14.28 Million USD | -15.43% |
| 2018 | 16.89 Million USD | 11.7% |
| 2017 | 15.12 Million USD | -25.52% |
| 2016 | 20.3 Million USD | 27.32% |
| 2015 | 15.95 Million USD | -12.23% |
| 2014 | 18.17 Million USD | -15.6% |
| 2013 | 21.53 Million USD | -18.69% |
| 2012 | 26.47 Million USD | 24.2% |
| 2011 | 21.31 Million USD | 141.56% |
| 2010 | 8.82 Million USD | -56.01% |
| 2009 | 20.06 Million USD | -38.58% |
| 2008 | 32.66 Million USD | -5.4% |
| 2007 | 34.52 Million USD | -5.38% |
| 2006 | 36.48 Million USD | 18.45% |
| 2005 | 30.8 Million USD | -14.45% |
| 2004 | 36 Million USD | 14.13% |
| 2003 | 31.55 Million USD | 74.34% |
| 2002 | 18.09 Million USD | 70.92% |
| 2001 | 10.58 Million USD | 112.0% |
| 2000 | 4.99 Million USD | 68.45% |
| 1999 | 2.96 Million USD | 1382.46% |
| 1998 | 200 Thousand USD | -50.0% |
| 1997 | 400 Thousand USD | 100.0% |
| 1996 | 200 Thousand USD | -66.67% |
| 1995 | 600 Thousand USD | 100.0% |
| 1994 | 300 Thousand USD | 200.0% |
| 1993 | 100 Thousand USD | -95.24% |
| 1992 | 2.1 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 3.33 Million USD | -5.33% |
| 2024 Q2 | 4.6 Million USD | 38.16% |
| 2023 Q3 | 3.74 Million USD | -38.77% |
| 2023 Q1 | 3.33 Million USD | -7.2% |
| 2023 Q4 | 3.52 Million USD | -5.93% |
| 2023 FY | 16.72 Million USD | 5.11% |
| 2023 Q2 | 6.11 Million USD | 83.34% |
| 2022 Q2 | 5.14 Million USD | 8.71% |
| 2022 Q4 | 3.59 Million USD | 47.08% |
| 2022 FY | 15.91 Million USD | -3.74% |
| 2022 Q3 | 2.44 Million USD | -52.44% |
| 2022 Q1 | 4.72 Million USD | -3.61% |
| 2021 Q3 | 4.84 Million USD | 19.82% |
| 2021 Q4 | 4.9 Million USD | 1.32% |
| 2021 FY | 16.52 Million USD | 167.76% |
| 2021 Q1 | 2.74 Million USD | 70.78% |
| 2021 Q2 | 4.04 Million USD | 47.43% |
| 2020 Q3 | 2.27 Million USD | 141.66% |
| 2020 Q2 | 941 Thousand USD | -30.45% |
| 2020 Q1 | 1.35 Million USD | -69.37% |
| 2020 FY | 6.17 Million USD | -56.8% |
| 2020 Q4 | 1.6 Million USD | -29.42% |
| 2019 Q4 | 4.41 Million USD | 48.77% |
| 2019 FY | 14.28 Million USD | -15.43% |
| 2019 Q2 | 3.38 Million USD | -4.03% |
| 2019 Q1 | 3.52 Million USD | -37.25% |
| 2019 Q3 | 2.96 Million USD | -12.16% |
| 2018 Q1 | 3.03 Million USD | -16.08% |
| 2018 FY | 16.89 Million USD | 11.7% |
| 2018 Q4 | 5.61 Million USD | 42.43% |
| 2018 Q3 | 3.94 Million USD | -8.52% |
| 2018 Q2 | 4.3 Million USD | 42.04% |
| 2017 Q1 | 3.95 Million USD | -26.84% |
| 2017 Q3 | 2.85 Million USD | -39.31% |
| 2017 Q4 | 3.61 Million USD | 26.58% |
| 2017 FY | 15.12 Million USD | -25.52% |
| 2017 Q2 | 4.7 Million USD | 19.0% |
| 2016 FY | 20.3 Million USD | 27.32% |
| 2016 Q4 | 5.4 Million USD | -3.6% |
| 2016 Q3 | 5.6 Million USD | -0.9% |
| 2016 Q2 | 5.65 Million USD | 55.21% |
| 2016 Q1 | 3.64 Million USD | -35.6% |
| 2015 Q3 | 3.38 Million USD | -8.65% |
| 2015 Q4 | 5.65 Million USD | 67.35% |
| 2015 FY | 15.95 Million USD | -12.23% |
| 2015 Q2 | 3.7 Million USD | 15.3% |
| 2015 Q1 | 3.21 Million USD | -37.17% |
| 2014 FY | 18.17 Million USD | -15.6% |
| 2014 Q2 | 3.72 Million USD | -5.38% |
| 2014 Q3 | 5.39 Million USD | 44.62% |
| 2014 Q4 | 5.1 Million USD | -5.27% |
| 2014 Q1 | 3.94 Million USD | -37.9% |
| 2013 Q4 | 6.34 Million USD | 65.74% |
| 2013 Q3 | 3.82 Million USD | -31.15% |
| 2013 Q2 | 5.56 Million USD | -4.02% |
| 2013 Q1 | 5.79 Million USD | -34.83% |
| 2013 FY | 21.53 Million USD | -18.69% |
| 2012 FY | 26.47 Million USD | 24.2% |
| 2012 Q4 | 8.89 Million USD | 41.54% |
| 2012 Q3 | 6.28 Million USD | 14.2% |
| 2012 Q2 | 5.5 Million USD | -5.29% |
| 2012 Q1 | 5.8 Million USD | 4.67% |
| 2011 Q1 | 4.83 Million USD | 0.12% |
| 2011 Q2 | 5.61 Million USD | 16.0% |
| 2011 Q3 | 5.31 Million USD | -5.26% |
| 2011 Q4 | 5.54 Million USD | 4.32% |
| 2011 FY | 21.31 Million USD | 141.56% |
| 2010 Q3 | 1.79 Million USD | -7.25% |
| 2010 Q4 | 4.83 Million USD | 169.85% |
| 2010 Q1 | 270 Thousand USD | -93.81% |
| 2010 FY | 8.82 Million USD | -56.01% |
| 2010 Q2 | 1.93 Million USD | 615.19% |
| 2009 Q4 | 4.36 Million USD | -25.2% |
| 2009 Q2 | 8.09 Million USD | 358.03% |
| 2009 FY | 20.06 Million USD | -38.58% |
| 2009 Q3 | 5.83 Million USD | -27.97% |
| 2009 Q1 | 1.76 Million USD | -67.51% |
| 2008 Q2 | 10.1 Million USD | 5.48% |
| 2008 Q1 | 9.58 Million USD | -2.16% |
| 2008 Q3 | 7.53 Million USD | -25.49% |
| 2008 FY | 32.66 Million USD | -5.4% |
| 2008 Q4 | 5.44 Million USD | -27.74% |
| 2007 Q3 | 6.58 Million USD | -34.23% |
| 2007 FY | 34.52 Million USD | -5.38% |
| 2007 Q2 | 10.01 Million USD | 23.02% |
| 2007 Q1 | 8.13 Million USD | -29.71% |
| 2007 Q4 | 9.79 Million USD | 48.75% |
| 2006 Q1 | 8.74 Million USD | -11.22% |
| 2006 FY | 36.48 Million USD | 18.45% |
| 2006 Q3 | 8.61 Million USD | 14.09% |
| 2006 Q4 | 11.57 Million USD | 34.38% |
| 2006 Q2 | 7.55 Million USD | -13.66% |
| 2005 FY | 30.8 Million USD | -14.45% |
| 2005 Q4 | 9.85 Million USD | 85.73% |
| 2005 Q3 | 5.3 Million USD | -15.57% |
| 2005 Q2 | 6.28 Million USD | -32.95% |
| 2005 Q1 | 9.36 Million USD | -8.89% |
| 2004 FY | 36 Million USD | 14.13% |
| 2004 Q3 | 7.05 Million USD | -27.23% |
| 2004 Q1 | 9.28 Million USD | -15.16% |
| 2004 Q2 | 9.7 Million USD | 4.46% |
| 2004 Q4 | 10.28 Million USD | 45.67% |
| 2003 FY | 31.55 Million USD | 74.34% |
| 2003 Q2 | 6.34 Million USD | 14.7% |
| 2003 Q1 | 5.53 Million USD | -9.06% |
| 2003 Q3 | 8.41 Million USD | 32.57% |
| 2003 Q4 | 10.94 Million USD | 30.15% |
| 2002 Q2 | 4.34 Million USD | 39.12% |
| 2002 Q4 | 6.08 Million USD | 33.61% |
| 2002 Q1 | 3.12 Million USD | -9.61% |
| 2002 Q3 | 4.55 Million USD | 4.84% |
| 2002 FY | 18.09 Million USD | 70.92% |
| 2001 FY | 10.58 Million USD | 112.0% |
| 2001 Q3 | 2.8 Million USD | 7.84% |
| 2001 Q1 | 1.78 Million USD | -22.66% |
| 2001 Q2 | 2.6 Million USD | 45.48% |
| 2001 Q4 | 3.45 Million USD | 23.1% |
| 2000 Q1 | 562.27 Thousand USD | -15.44% |
| 2000 Q4 | 2.31 Million USD | 120.11% |
| 2000 FY | 4.99 Million USD | 68.45% |
| 2000 Q3 | 1.05 Million USD | -1.83% |
| 2000 Q2 | 1.06 Million USD | 90.27% |
| 1999 FY | 2.96 Million USD | 1382.46% |
| 1999 Q1 | 800 Thousand USD | 300.0% |
| 1999 Q2 | 600 Thousand USD | -25.0% |
| 1999 Q3 | 800 Thousand USD | 33.33% |
| 1999 Q4 | 664.91 Thousand USD | -16.89% |
| 1998 Q1 | 100 Thousand USD | 0.0% |
| 1998 FY | 200 Thousand USD | -50.0% |
| 1998 Q2 | -100 Thousand USD | -200.0% |
| 1998 Q3 | - USD | 100.0% |
| 1998 Q4 | 200 Thousand USD | 0.0% |
| 1997 Q1 | - USD | -100.0% |
| 1997 FY | 400 Thousand USD | 100.0% |
| 1997 Q4 | - USD | -100.0% |
| 1997 Q3 | 200 Thousand USD | 100.0% |
| 1997 Q2 | 100 Thousand USD | 0.0% |
| 1996 Q2 | 200 Thousand USD | 0.0% |
| 1996 Q1 | - USD | -100.0% |
| 1996 FY | 200 Thousand USD | -66.67% |
| 1996 Q4 | 200 Thousand USD | 0.0% |
| 1996 Q3 | - USD | -100.0% |
| 1995 Q4 | 200 Thousand USD | 0.0% |
| 1995 Q2 | 100 Thousand USD | 0.0% |
| 1995 Q1 | 100 Thousand USD | 0.0% |
| 1995 Q3 | 200 Thousand USD | 100.0% |
| 1995 FY | 600 Thousand USD | 100.0% |
| 1994 Q2 | 300 Thousand USD | 50.0% |
| 1994 Q4 | - USD | 0.0% |
| 1994 Q3 | - USD | -100.0% |
| 1994 Q1 | 200 Thousand USD | 166.67% |
| 1994 FY | 300 Thousand USD | 200.0% |
| 1993 Q4 | -300 Thousand USD | -400.0% |
| 1993 FY | 100 Thousand USD | -95.24% |
| 1993 Q3 | 100 Thousand USD | 0.0% |
| 1993 Q2 | 100 Thousand USD | -50.0% |
| 1993 Q1 | 200 Thousand USD | -33.33% |
| 1992 FY | 2.1 Million USD | 0.0% |
| 1992 Q4 | 300 Thousand USD | 0.0% |
| 1992 Q2 | 700 Thousand USD | -50.0% |
| 1992 Q3 | 300 Thousand USD | -57.14% |
| 1992 Q1 | 1.4 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -555.843% |
| BrainsWay Ltd. | 23.09 Million USD | 27.574% |
| Cerus Corporation | 86.4 Million USD | 80.644% |
| Envoy Medical, Inc. | -473 Thousand USD | 3635.73% |
| electroCore, Inc. | 13.22 Million USD | -26.448% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -27316.395% |
| IceCure Medical Ltd | 1.3 Million USD | -1186.462% |
| Inogen, Inc. | 126.69 Million USD | 86.8% |
| OrthoPediatrics Corp. | 111.25 Million USD | 84.968% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 376.43% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 35430.406% |
| MaxCyte, Inc. | 36.54 Million USD | 54.238% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -3563.391% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -19561.417% |
| Orthofix Medical Inc. | 486.27 Million USD | 96.561% |
| PAVmed Inc | -3.96 Million USD | 521.472% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 404.904% |
| RxSight, Inc. | 53.76 Million USD | 68.894% |
| Sight Sciences, Inc. | 69.17 Million USD | 75.824% |
| SI-BONE, Inc. | 109.42 Million USD | 84.716% |
| TELA Bio, Inc. | 40.11 Million USD | 58.307% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 88.993% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -102.2% |
| Acutus Medical, Inc. | -3.13 Million USD | 633.121% |
| Talis Biomedical Corporation | 371 Thousand USD | -4407.817% |
| Spectral AI, Inc. | 7.88 Million USD | -112.234% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 353.701% |
| CVRx, Inc. | 33.03 Million USD | 49.381% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -2161.449% |
| Bioventus Inc. | 328.19 Million USD | 94.904% |
| Venus Concept Inc. | 52.16 Million USD | 67.941% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -5.143% |
| LivaNova PLC | 771.25 Million USD | 97.832% |
| 908 Devices Inc. | 25.32 Million USD | 33.955% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 94.609% |
| Nemaura Medical Inc. | -1.47 Million USD | 1232.762% |
| NeuroPace, Inc. | 48.12 Million USD | 65.247% |
| LENSAR, Inc. | 21.1 Million USD | 20.766% |
| Apyx Medical Corporation | 14.12 Million USD | -18.425% |
| Cutera, Inc. | 41.49 Million USD | 59.695% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 9.409% |
| BioSig Technologies, Inc. | 18 Thousand USD | -92811.117% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 83.777% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -22.844% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 98.117% |
| Axonics, Inc. | 274.55 Million USD | 93.909% |
| Outset Medical, Inc. | 29 Million USD | 42.331% |
| IRIDEX Corporation | 21.8 Million USD | 23.309% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 76.461% |
| IRadimed Corporation | 50.15 Million USD | 66.658% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -5727.178% |
| INVO Bioscience, Inc. | 1.08 Million USD | -1439.768% |
| Telesis Bio, Inc. | 16.95 Million USD | 1.333% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 85.172% |
| Varex Imaging Corporation | 256.9 Million USD | 93.49% |
| Quipt Home Medical Corp. | 163.84 Million USD | 89.793% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 4219.212% |
| Pulmonx Corporation | 50.75 Million USD | 67.048% |
| Dynatronics Corporation | 7.63 Million USD | -119.045% |
| Modular Medical, Inc. | -768 Thousand USD | 2277.604% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -201.442% |
| Semler Scientific, Inc. | 61.2 Million USD | 72.673% |
| InMode Ltd. | 411.34 Million USD | 95.934% |
| Bruker Corporation | 1.51 Billion USD | 98.897% |
| Cytosorbents Corporation | 22.39 Million USD | 25.313% |
| DexCom, Inc. | 2.28 Billion USD | 99.269% |
| Align Technology, Inc. | 2.71 Billion USD | 99.385% |
| Viveve Medical, Inc. | 620 Thousand USD | -2597.42% |
| ZimVie Inc. | 290.38 Million USD | 94.241% |
| Movano Inc. | -158 Thousand USD | 10684.811% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 84.717% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -19561.417% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 95.452% |
| Profound Medical Corp. | 4.51 Million USD | -270.49% |
| Insulet Corporation | 1.15 Billion USD | 98.558% |
| enVVeno Medical Corporation | -546 Thousand USD | 3163.004% |
| Surmodics, Inc. | 93.05 Million USD | 82.027% |
| iCAD, Inc. | 14.53 Million USD | -15.052% |
| Nuwellis, Inc. | 4.98 Million USD | -235.621% |
| Biotricity, Inc. | 8.35 Million USD | -100.137% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 94.96% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 4757.757% |
| InspireMD, Inc. | 1.8 Million USD | -825.512% |
| PAVmed Inc. | -3.96 Million USD | 521.472% |
| Beyond Air, Inc. | -1.3 Million USD | 1379.572% |
| FONAR Corporation | 45.14 Million USD | 62.951% |
| AxoGen, Inc. | 127.87 Million USD | 86.922% |
| Vivani Medical, Inc. | -357 Thousand USD | 4784.594% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 91.429% |
| Inari Medical, Inc. | 434.56 Million USD | 96.152% |
| UFP Technologies, Inc. | 112.22 Million USD | 85.098% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -133488.953% |
| Tenon Medical, Inc. | 1.24 Million USD | -1247.623% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 20746.915% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -536.598% |
| AdaptHealth Corp. | 479.56 Million USD | 96.513% |
| Sintx Technologies, Inc. | 1.84 Million USD | -807.434% |
| NanoVibronix, Inc. | 1.53 Million USD | -988.094% |
| Quanterix Corporation | 70.64 Million USD | 76.327% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 4219.212% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -18.947% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 68.314% |
| TransMedics Group, Inc. | 154.09 Million USD | 89.147% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -275.567% |
| NeuroMetrix, Inc. | 3.94 Million USD | -323.67% |
| Hyperfine, Inc. | 4.75 Million USD | -251.566% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 84.367% |
| Biomerica, Inc. | 611 Thousand USD | -2637.152% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 59.882% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 2241.481% |
| Silk Road Medical, Inc | 127.08 Million USD | 86.84% |